2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
FDA Comment Number : | EC3136 | |||||||||||||||||||||||
Submitter : | Mr. James Price | Date & Time: | 12/14/2006 01:12:05 | |||||||||||||||||||||
Organization : | SANCTUS, LLC | |||||||||||||||||||||||
Category : | Individual Consumer | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
Use of cell lines garnered from human embryos and any other stage of fetal development should be disallowed. Period.
Thanks | ||||||||||||||||||||||||